Retraction: Indole-3-Carbinol Inhibits Nasopharyngeal Carcinoma Growth through Cell Cycle Arrest In Vivo and In Vitro (PLoS ONE (2013) 8:12 (e82288) DOI: 10.1371/journal.pone.0082288);Indole-3-carbinol inhibits nasopharyngeal carcinoma growth through cell cycle arrest in vivo and in vitro

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Chen, Zhe ^a   Tao, Ze Zhang ^a   Chen, Shi Ming ^a   Chen, Chen ^a   Li, Fen ^a   Xiao, Bo Kui ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 INDOLEMETHANOL; CELL CYCLE PROTEIN; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; PLANT MEDICINAL PRODUCT; PROTEIN PRB; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER PREVENTION; CANCER THERAPY; CELL CYCLE ARREST; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG SAFETY; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; TUMOR XENOGRAFT;

ANIMALS; APOPTOSIS; CARCINOMA; CELL CYCLE; CELL CYCLE CHECKPOINTS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASES; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INDOLES; MICE; NASOPHARYNGEAL NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 84892777370     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0275881     Document Type: Erratum

References (45)

1. Lee AW, Sze WM, Au JS, Leung SF, Leung TW, et al. (2005) Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. Int J Radiat Oncol Biol Phys 61: 1107-1116.
2. Chan ATC (2010) Nasopharyngeal carcinoma. Annals of Oncology 21: vii308-vii312.
3. Chinni SR, Li Y, Upadhyay S, Koppolu PK, Sarkar FH (2001) Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells. Oncogene 20: 2927-2936.
4. Nachshon-Kedmi M, Yannai S, Haj A, Fares FA (2003) Indole-3-carbinol and 3,3′-diindolylmethane induce apoptosis in human prostate cancer cells. Food Chem Toxicol 41: 745-752.
5. Hsu JC, Dev A, Wing A, Brew CT, Bjeldanes LF, et al. (2006) Indole-3-carbinol mediated cell cycle arrest of LNCaP human prostate cancer cells requires the induced production of activated p53 tumor suppressor protein. Biochem Pharmacol 72: 1714-1723.
6. Zhang J, Hsu BAJ, Kinseth BAM, Bjeldanes LF, Firestone GL (2003) Indole-3-carbinol induces a G1 cell cycle arrest and inhibits prostate-specific antigen production in human LNCaP prostate carcinoma cells. Cancer 98: 2511-2520.
7. Takada Y, Andreeff M, Aggarwal BB (2005) Indole-3-carbinol suppresses NFkappaB and IkappaBalpha kinase activation, causing inhibition of expression of NF-kappaB-regulated antiapoptotic and metastatic gene products and enhancement of apoptosis in myeloid and leukemia cells. Blood 106: 641-649.
8. Wu HT, Lin SH, Chen YH (2005) Inhibition of cell proliferation and in vitro markers of angiogenesis by indole-3-carbinol, a major indole metabolite present in cruciferous vegetables. J Agric Food Chem 53: 5164-5169.
9. Aggarwal BB, Ichikawa H (2005) Molecular targets and anticancer potential of indole-3-carbinol and its derivatives. Cell Cycle 4: 1201-1215.
10. Ping J, Gao AM, Qin HQ, Wei XN, Bai J, et al. (2011) Indole-3-carbinol enhances the resolution of rat liver fibrosis and stimulates hepatic stellate cell apoptosis by blocking the inhibitor of kappaB kinase alpha/inhibitor of kappaBalpha/nuclear factor-kappaB pathway. J Pharmacol Exp Ther 339: 694-703.
11. Ping J, Li JT, Liao ZX, Shang L, Wang H (2011) Indole-3-carbinol inhibits hepatic stellate cells proliferation by blocking NADPH oxidase/reactive oxygen species/p38 MAPK pathway. Eur J Pharmacol 650: 656-662.
12. Zhao P, Fu J, Yao B, Hu E, Song Y, et al. (2013) Diethyl sulfate-induced cell cycle arrest and apoptosis in human bronchial epithelial 16HBE cells. Chem Biol Interact 205: 81-89.
13. Wu A, Luo W, Zhang Q, Yang Z, Zhang G, et al. (2013) Aldehyde dehydrogenase 1, a functional marker for identifying cancer stem cells in human nasopharyngeal carcinoma. Cancer Lett 330: 181-189.
14. Yang Y, Liao Q, Wei F, Li X, Zhang W, et al. (2013) LPLUNC1 inhibits nasopharyngeal carcinoma cell growth via down-regulation of the MAP kinase and cyclin D1/E2F pathways. PLoS One 8: e62869.
15. Han JB, Tao ZZ, Chen SM, Kong YG, Xiao BK (2011) Adenovirus-mediated transfer of tris-shRNAs induced apoptosis of nasopharyngeal carcinoma cell in vitro and in vivo. Cancer Lett 309: 162-169.
16. Wang Y, Tao ZZ, Chen SM, Xiao BK, Zhou XH, et al. (2008) Application of combination of short hairpin RNA segments for silencing VEGF, TERT and Bcl-xl expression in laryngeal squamous carcinoma. Cancer Biol Ther 7: 896-901.
17. Xie Y, Li Y, Peng X, Henderson F Jr, Deng L, et al. (2013) Ikappa B kinase alpha involvement in the development of nasopharyngeal carcinoma through a NF-kappaB-independent and ERK-dependent pathway. Oral Oncol.
18. Teo PM, Kwan WH, Lee WY, Leung SF, Johnson PJ (1996) Prognosticators determining survival subsequent to distant metastasis from nasopharyngeal carcinoma. Cancer 77: 2423-2431.
19. Sham JS, Choy D, Choi PH (1990) Nasopharyngeal carcinoma: the significance of neck node involvement in relation to the pattern of distant failure. Br J Radiol 63: 108-113.
20. Ma BB, Chan AT (2005) Recent perspectives in the role of chemotherapy in the management of advanced nasopharyngeal carcinoma. Cancer 103: 22-31.
21. Marconett CN, Sundar SN, Tseng M, Tin AS, Tran KQ, et al. (2011) Indole-3-carbinol downregulation of telomerase gene expression requires the inhibition of estrogen receptor-alpha and Sp1 transcription factor interactions within the hTERT promoter and mediates the G1 cell cycle arrest of human breast cancer cells. Carcinogenesis 32: 1315-1323.
22. Choi H-S, Cho M-C, Lee HG, Yoon D-Y (2010) Indole-3-carbinol induces apoptosis through p53 and activation of caspase-8 pathway in lung cancer A549 cells. Food and Chemical Toxicology 48: 883-890.
23. Xu Y, Zhang J, Dong WG (2011) Indole-3-carbinol (I3C)-induced apoptosis in nasopharyngeal cancer cells through Fas/FasL and MAPK pathway. Med Oncol 28: 1343-1348.
24. Zhu W, Li W, Yang G, Zhang Q, Li M, et al. (2010) Indole-3-carbinol inhibits nasopharyngeal carcinoma. Int J Toxicol 29: 185-192.
25. Ye M, Luo X, Li L, Shi Y, Tan M, et al. (2007) Grifolin, a potential antitumor natural product from the mushroom Albatrellus confluens, induces cell-cycle arrest in G1 phase via the ERK1/2 pathway. Cancer Lett 258: 199-207.
26. Liu DB, Hu GY, Long GX, Qiu H, Mei Q, et al. (2012) Celecoxib induces apoptosis and cell-cycle arrest in nasopharyngeal carcinoma cell lines via inhibition of STAT3 phosphorylation. Acta Pharmacol Sin 33: 682-690.
27. Ong CS, Zhou J, Ong CN, Shen HM (2010) Luteolin induces G1 arrest in human nasopharyngeal carcinoma cells via the Akt-GSK-3beta-Cyclin D1 pathway. Cancer Lett 298: 167-175.
28. Hirama T, Koeffler HP (1995) Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood 86: 841-854.
29. Sherr CJ (1995) D-type cyclins. Trends Biochem Sci 20: 187-190.
30. Sherr CJ (1996) Cancer cell cycles. Science 274: 1672-1677.
31. Zuo L, Weger J, Yang Q, Goldstein AM, Tucker MA, et al. (1996) Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma. Nat Genet 12: 97-99.
32. Paggi MG, Baldi A, Bonetto F, Giordano A (1996) Retinoblastoma protein family in cell cycle and cancer: a review. J Cell Biochem 62: 418-430.
33. Zhang W, Zeng Z, Zhou Y, Xiong W, Fan S, et al. (2009) Identification of aberrant cell cycle regulation in Epstein-Barr virus-associated nasopharyngeal carcinoma by cDNA microarray and gene set enrichment analysis. Acta Biochim Biophys Sin (Shanghai) 41: 414-428.
34. Aggarwal BB (2004) Nuclear factor-kappaB: the enemy within. Cancer Cell 6: 203-208.
35. Orlowski RZ, Baldwin AS Jr (2002) NF-kappaB as a therapeutic target in cancer. Trends Mol Med 8: 385-389.
36. Grose KR, Bjeldanes LF (1992) Oligomerization of indole-3-carbinol in aqueous acid. Chem Res Toxicol 5: 188-193.
37. Kim DS, Jeong YM, Moon SI, Kim SY, Kwon SB, et al. (2006) Indole-3-carbinol enhances ultraviolet B-induced apoptosis by sensitizing human melanoma cells. Cell Mol Life Sci 63: 2661-2668.
38. Chen DZ, Qi M, Auborn KJ, Carter TH (2001) Indole-3-carbinol and diindolylmethane induce apoptosis of human cervical cancer cells and in murine HPV16-transgenic preneoplastic cervical epithelium. J Nutr 131: 3294-3302.
39. Weng JR, Tsai CH, Kulp SK, Wang D, Lin CH, et al. (2007) A potent indole-3- carbinol derived antitumor agent with pleiotropic effects on multiple signaling pathways in prostate cancer cells. Cancer Res 67: 7815-7824.
40. Moiseeva EP, Fox LH, Howells LM, Temple LA, Manson MM (2006) Indole-3-carbinol-induced death in cancer cells involves EGFR downregulation and is exacerbated in a 3D environment. Apoptosis 11: 799-812.
41. Anderton MJ, Jukes R, Lamb JH, Manson MM, Gescher A, et al. (2003) Liquid chromatographic assay for the simultaneous determination of indole-3-carbinol and its acid condensation products in plasma. J Chromatogr B Analyt Technol Biomed Life Sci 787: 281-291.
42. Reed GA, Arneson DW, Putnam WC, Smith HJ, Gray JC, et al. (2006) Single-dose and multiple-dose administration of indole-3-carbinol to women: pharmacokinetics based on 3,39-diindolylmethane. Cancer Epidemiol Biomarkers Prev 15: 2477-2481.
43. Anderton MJ, Manson MM, Verschoyle RD, Gescher A, Lamb JH, et al. (2004) Pharmacokinetics and tissue disposition of indole-3-carbinol and its acid condensation products after oral administration to mice. Clin Cancer Res 10: 5233-5241.
44. Reed GA, Peterson KS, Smith HJ, Gray JC, Sullivan DK, et al. (2005) A phase I study of indole-3-carbinol in women: tolerability and effects. Cancer Epidemiol Biomarkers Prev 14: 1953-1960.
45. Reagan-Shaw S, Nihal M, Ahmad N (2008) Dose translation from animal to human studies revisited. FASEB J 22: 659-661.